Abstract
PURPOSE:: To report on a series of white patients in the United States with polypoidal choroidal vasculopathy (PCV). METHODS:: This is a retrospective chart review of 27 patients at a single center with PCV. RESULTS:: The mean age was 74.3 with 48% being male. The most common presenting diagnosis was exudative age-related macular degeneration in 59%, and it took 17.5 months to diagnose PCV. During this time, patients received one antivascular endothelial growth factor injection every 1.3 months. The most common reason for suspecting PCV was a large retinal pigment epithelial detachment or a poor response to antivascular endothelial growth factor therapy. Once PCV was diagnosed, most underwent photodynamic therapy. In those who received photodynamic therapy, the fluid and/or age-related macular degeneration decreased in 86%. The vision improved in 41% with 36% maintaining stable vision. Patients received only one additional injection every 3.95 months after photodynamic therapy. CONCLUSION:: This is one of the larger series of PCV in an entirely white population. It emphasizes the importance of diagnosis in whites as PCV can masquerade as recalcitrant exudative age-related macular degeneration. Common findings were a temporal or peripapillary location and the presence of lipid. After photodynamic therapy, the patients still required antivascular endothelial growth factor therapy, but the injection burden was decreased by 67% and vision was found to be improved or maintained in 77% of patients.
Original language | English (US) |
---|---|
Pages (from-to) | 2185-2191 |
Number of pages | 7 |
Journal | Retina |
Volume | 34 |
Issue number | 11 |
DOIs | |
State | Published - Nov 12 2014 |
Keywords
- age-related macular degeneration
- avastin
- bevacizumab
- indocyanine green
- photodynamic therapy
- pigment epithelial detachment
- ranibizumab
- white
ASJC Scopus subject areas
- Ophthalmology